Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit for its safety in breastfeeding.

What is Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit used for?


RAJANI is an estrogen/progestin COC containing a folate, indicated for use by women to: Prevent pregnancy. (1.1) Treat symptoms of premenstrual dysphoric disorder (PMDD) for women who choose to use an oral contraceptive for contraception. (1.2) Treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control. (1.3) Raise folate levels in women who choose to use an oral contraceptive for contraception. (1.4) 1.1 Oral Contraceptive RAJANI is indicated for use by women to prevent pregnancy. 1.2 Premenstrual Dysphoric Disorder (PMDD) RAJANI is also indicated for the treatment of symptoms of premenstrual dysphoric disorder (PMDD) in women who choose to use an oral contraceptive as their method of contraception. The effectiveness of RAJANI for PMDD when used for more than three menstrual cycles has not been evaluated. The essential features of PMDD according to the Diagnostic and Statistical Manual-4th edition (DSM-IV) include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. Other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. Physical symptoms associated with PMDD include breast tenderness, headache, joint and muscle pain, bloating and weight gain. In this disorder, these symptoms occur regularly during the luteal phase and remit within a few days following onset of menses; the disturbance markedly interferes with work or school, or with usual social activities and relationships with others. Diagnosis is made by healthcare providers according to DSM-IV criteria, with symptomatology assessed prospectively over at least two menstrual cycles. In making the diagnosis, care should be taken to rule out other cyclical mood disorders. RAJANI has not been evaluated for the treatment of premenstrual syndrome (PMS). 1.3 Acne RAJANI is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. RAJANI should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control. 1.4 Folate Supplementation RAJANI is indicated in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

Can I continue breastfeeding if I am using Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit? How long does it stays in breast milk?

Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit Contains 4 active ingredients that are Drospirenone, Ethinyl estradiol, Levomefolic acid, Levomefolic acid. We do have breastfeeding analysis and safety rating of some of the active ingredients but unfortunately we do not have any information of some of active ingredients used. Below we have provided whatever information we do have. But please do not take any decision based on below provided information and contact your health care provider as this information is incomplete.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers When possible, advise the nursing mother to use other forms of contraception until she has weaned her child. Estrogen-containing COCs can reduce milk production in breastfeeding mothers. This is less likely to occur once breastfeeding is well-established; however, it can occur at any time in some women. Small amounts of oral contraceptive steroids and/or metabolites are present in breast milk. After oral administration of 3 mg DRSP/0.03 mg EE tablets (Yasmin**), about 0.02% of the DRSP dose was excreted into the breast milk of postpartum women within 24 hours. This results in a maximal daily dose of about 0.003 mg DRSP in an infant. Studies to date indicate there is no adverse effect of folate on nursing infants.

Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit Breastfeeding Analsys


Drospirenone while Breastfeeding

Low Risk

Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit and breastfeeding

Birth control pill that contains the combination of an estrogen (Ethinyl estradiol) and a progestin (Drospirenone) for oral use. Ethinylestradiol is a synthetic estrogen with similar action than estradiol. Used in combination with progestogens for contraception.Ethinylestradiol is excreted into the breast milk in no or small amount.There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of ethinyl estradiol.It may reduce the protein content of the milk.No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. Drospirenone is an analogue of spironolactone which has the effects of progesterone. It is excreted into breast milk in clinically non-significant amount. With other similar combined contraceptives no differences have been observed in the frequency of breastfeeding or the amount of milk produced or weight gain of breastfed infants compared to other contraceptive methods (intrauterine devices, isolated progestogens). However, it would be advisable to avoid them until breastfeeding is well established (4-6 weeks). During lactation, progestin-only contraceptive pills are preferred to Estrogen containing ones, otherwise, the lowest estrogen dose should be used.During the first 6 postpartum weeks, non-hormonal methods are in the first line of choice. Hormone containing contraceptives do not affect the composition of milk, minerals (Mg, Fe, Cu, Ca, P) fat, lactose and calories but only a few the proteins.

Ethinyl estradiol while Breastfeeding

Low Risk

CAS Number: 57-63-6

Synthetic estrogen that has a similar action as estradiol. Used in combination with progestogens for contraception. Ethinylestradiol is excreted in small or no amount into breast milk.There is evidence (albeit inconsistent) that estrogen-containing pills may decrease milk production, especially during the first few weeks postpartum with a daily dose above 30 micrograms of ethinyl estradiol.It may reduce the protein content of the milk.No problems have been observed in infants whose mothers were treated, except some cases of transient gynecomastia in infants whose mothers were receiving a higher dose than usual. During lactation progestin-only drugs are preferred or in combination with estrogen for birth control, but whatever, the ones with the lower doses of estrogen should be used.For the first 6 weeks postpartum, non-hormonal methods are of choise.

Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit Breastfeeding Analsys - 2


Drospirenone while Breastfeeding

CAS Number: 67392-87-4

Drospirenone is a progestin that is an analogue of spironolactone. It has antimineralocorticoid and antiandrogenic activities and is available in the U.S. only in combination with ethinyl estradiol as an oral contraceptive agent. Based on the available evidence, expert opinion holds that nonhormonal methods are preferred during breastfeeding and progestin-only contraceptive are preferred over combined oral contraceptives in breastfeeding women, especially during the first 4 weeks postpartum. For further information, consult the record entitled, "Contraceptives, Oral, Combined."

Ethinyl estradiol while Breastfeeding

CAS Number: 57-63-6

Is Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit safe while breastfeeding

This record contains information specific to ethinyl estradiol used alone. Users with an interest in an oral contraceptive should consult the record entitled, "Contraceptives, Oral, Combined."There is little information available on the use of ethinyl estradiol alone during breastfeeding. Levels in milk appear to be low. Based on studies on oral contraceptives that contain ethinyl estradiol, immediate side effects such as breast enlargement appear to occur rarely. It seems likely that doses of 30 mcg daily or greater can suppress lactation. The magnitude of the effect on lactation likely depends on the dose and the time of introduction postpartum, but data are not adequate to accurately define these doses and times.

Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit safe for breastfeeding

I already used Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit and meanwhile I breastfed my baby should I be concerned?

Not much study has been done on safety of Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit in breastfeeding and its ingredients. Even we do not have complete information about usage of Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit in breastfeeding so at this point a trained medical professional could be your best bet. If you observe anything abnormal with your baby please contact 911.


My doctor has prescribed me Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit, what should I do?

If your doctor considers Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit safe enough to prescribe for you that means its benefits should outweigh its known risks for you.


If I am using Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit, will my baby need extra monitoring?

We are not Sure, Please check with your healthcare provider or doctor.


Who can I talk to if I have questions about usage of Rajani | Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Kit in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week